美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

GenEmbryomics Limited

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：1.25億

流通股本：109.50萬

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：-763.51%

市淨率：0.00

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

GenEmbryomics Limited

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.genembryomics.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

GenEmbryomics Limited於2019年1月18日根據澳大利亞維多利亞州法律成立為一家股份有限公司。該公司是一家基於基因組學的公司，其使命是通過為體外受精患者和提供者提供對胚胎遺傳疾病的無與倫比的見解，使家庭能夠擁有健康的孩子。公司旗艦測試Panacea GenomeScreen通過個人、夫婦和體外受精胚胎的全基因組測序提供植入前基因檢測。該公司正在與美國的外包合作夥伴以及歐洲、拉丁美洲和印度的潛在合作夥伴建立全球實驗室網絡。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/XGEN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XGEN\",,,,,undefined,":{"symbol":"XGEN","market":"US","secType":"STK","nameCN":"GenEmbryomics Limited","latestPrice":0,"timestamp":1774036800000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":1095000,"shares":124552942,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"03-20 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1746158400000,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XGEN\",,,,,undefined,":{"symbol":"XGEN","floatShares":1095000,"roa":"-763.51%","roe":"--","lyrEps":0,"shares":124552942,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"0.00","psRate":"0.00","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XGEN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XGEN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.genembryomics.com","compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"GenEmbryomics Limited於2019年1月18日根據澳大利亞維多利亞州法律成立為一家股份有限公司。該公司是一家基於基因組學的公司，其使命是通過為體外受精患者和提供者提供對胚胎遺傳疾病的無與倫比的見解，使家庭能夠擁有健康的孩子。公司旗艦測試Panacea GenomeScreen通過個人、夫婦和體外受精胚胎的全基因組測序提供植入前基因檢測。該公司正在與美國的外包合作夥伴以及歐洲、拉丁美洲和印度的潛在合作夥伴建立全球實驗室網絡。","exchange":"NASDAQ","name":"GenEmbryomics Limited","nameEN":"GenEmbryomics Limited"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"XGEN\",market:\"US\",,,undefined,":null}}